| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5630046d898287c21fc66ec12f476a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc077ea121bd3c15bca0d33a972727a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6078782d74afb1d158c332215834f83a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2012-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a0c90bcbaf702474e4469f3836ef0d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afc0ff9ca4a4a98a7dad11465308be2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5425aced645a85293c81aaf4eb5ed481 |
| publicationDate |
2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012116370-A1 |
| titleOfInvention |
Methods and systems using pharmacokinetic and pharmacodynamic profiles in interferon-alpha therapeutic regimens |
| abstract |
Methodologies and systems relating to the delivery of interferon-a are provided. Analyses of clinical trial data show that observations of interferon-a pharmacokinetic profiles following its from delivery via a continuous infusion device can be correlated with viral responses to this therapeutic agent. Such information can be used, for example, to optimize the treatment of individuals infected with the hepatitis B and C viruses. |
| priorityDate |
2011-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |